Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IR responded to my question asking if licensing can continue during the dispute

with TPL by saying "Yes, the licensing can continue."

I don't know about the rest of you, but I needed that assurance coming from the horse's mouth. Whether it will continue is a question only time can answer. From today's price action, it looks to me like the Market believes it will. Corrections welcomed.

GLTAL

Share
New Message
Please login to post a reply